Millendo Therapeutics, Inc. MLND
Set alert
1.06 +1.06 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 11.15M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -2.26
- Beta
- 0.48
- Short ratio
- 0.98
- Inst. own
- 37.18%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 2, 2021
- 50-d avg
- 18.86
- 200-d avg
- 25.14
- 1y target
- 2.00
Analyst view
Consensus: hold
Hold
Price target (mean) 2.00
Recommendation trend
- 1 month ago 1
- 2 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.36 | -0.36 – -0.36 | -8.40 | +95.7% | 0 | 0.0% | 1 |
| Next quarter | -0.29 | -0.29 – -0.29 | -5.10 | +94.3% | 0 | 0.0% | 1 |
| Current year | -1.27 | -1.27 – -1.27 | -28.95 | +95.6% | 0 | 0.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -1.27 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 6, 2021 | Ladenburg Thalmann | Downgrade | Buy | Neutral |
| Jan 6, 2021 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Apr 7, 2020 | Oppenheimer | Downgrade | Outperform | Perform |
| Mar 25, 2020 | Citigroup | Maintained | — | Buy |
| Aug 13, 2019 | Oppenheimer | Maintained | — | Outperform |
| Jul 19, 2019 | Wedbush | Initiated | — | Outperform |
| Jul 16, 2019 | Oppenheimer | Initiated | — | Outperform |
| Mar 13, 2019 | Jefferies | Initiated | — | Buy |